CVAS-an interesting california-based biotech company here Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVAS-an interesting california-based biotech company here

CVAS 0.000400

0.0%

Oct 7 9:32 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (53)	8/30/2001 10:37:14 AM
From: keokalani'nui	Read Replies (1) of 126

No respect for small Corvas when street* is talking about small molecules and protease inhibitors* The company must have been thinking the same thing. Wow. Zoology and Biolgical Sciences must not pay. Thursday August 30, 8:30 am Eastern Time Press Release SOURCE: Corvas International, Inc. Corvas Names Laura G. Hansen, Ph.D., Director of Investor Relations And Corporate Communications SAN DIEGO, Aug. 30 /PRNewswire/ -- Corvas International, Inc. (Nasdaq: CVAS - news) announced today that Laura G. Hansen, Ph.D., has joined the Company as Director of Investor Relations and Corporate Communications. Dr. Hansen was most recently employed by Susan E. Atkins & Associates, San Diego's largest consulting firm facilitating investor and public relationships for companies focused on the Life Sciences. ``We welcome Laura to our senior management team at Corvas. Her scientific background coupled with her agency experience will help us effectively communicate to the investment community our scientific excellence and corporate strategy for our later-stage cardiovascular products and promising cancer pipeline,'' said Randall E. Woods, President and CEO. Dr. Hansen provided strategic investor and public relations counsel to numerous biotechnology and biopharmaceutical companies with Susan E. Atkins & Associates. She leveraged her educational and research background in the life sciences to help private and public companies develop and execute tailored communication programs with clear scientific and corporate messages. Dr. Hansen holds a B.S. in Zoology and a Ph.D. in Biological Sciences from the University of Texas at Austin.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next